Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6718173 | 0.83 | TLR7 (0.40) | TLR7TLR8 | |
| SCHEMBL4792760 | 0.81 | TLR7 (0.49) | TLR7TLR8 | |
| SCHEMBL14500918 | 0.80 | TLR7 (0.44) | TLR7TLR8 | |
| Hydrochloric Acid SCHEMBL4791679 | 0.79 | TLR7 (0.44) | TLR7TLR8 | |
| SCHEMBL4794901 | 0.79 | TLR7 (0.41) | TLR7TLR8 | |
| SCHEMBL4793849 | 0.79 | TLR7 (0.45) | TLR7TLR8 | |
| SCHEMBL4791577 | 0.78 | TLR7 (0.42) | TLR7TLR8 | |
| SCHEMBL4793823 | 0.78 | TLR7 (0.52) | TLR7TLR8 | |
| SCHEMBL6718165 | 0.78 | TLR7 (0.48) | TLR7TLR8 | |
| SCHEMBL4792342 | 0.77 | ALDH1A1 (0.39) | TLR7TLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6797718-B2 | Ether substituted imidazopyridines | 3M INNOVATIVE PROPERTIES COMPANY | 2004-09-28 | — | — | US | disclosed |
| US-20040010007-A1 | Ether substituted imidazopyridines | 3M INNOVATIVE PROPERTIES COMPANY | 2004-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040010007-A1 | Ether substituted imidazopyridines | IL2, IL4, MYD88 | TLR7 33/4885TLR8 45/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.